Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc.

NASDAQ:VIR

Overview | Financials
Company Name Vir Biotechnology, Inc.
Symbol VIR
Currency USD
Price 9.77
Market Cap 1,334,972,800
Dividend Yield 0%
52-week-range 7.12 - 13.09
Industry Biotechnology
Sector Healthcare
CEO Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Website https://www.vir.bio

An error occurred while fetching data.

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza

Related Stocks

Patterson Companies, Inc. logo

Patterson Companies, Inc.

PDCO

21.35 USD

Karuna Therapeutics, Inc. logo

Karuna Therapeutics, Inc.

KRTX

329.83 USD

GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc.

GDRX

5.04 USD

Certara, Inc. logo

Certara, Inc.

CERT

10.99 USD

Mirati Therapeutics, Inc. logo

Mirati Therapeutics, Inc.

MRTX

58.7 USD

Progyny, Inc. logo

Progyny, Inc.

PGNY

16.53 USD

Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc.

NTLA

16 USD

Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc.

RARE

50.43 USD

Financials

Numbers are in millions USD

Numbers are in millions USD